CSIMarket
 


Patterson Companies Inc   (PDCO)
Other Ticker:  
 


Patterson Companies Inc's ROI from its second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Patterson Companies Inc's ROI in the second quarter of 2024?
Patterson Companies Inc achieved a return on average invested assets (ROI) of 11.56 % in its second quarter of 2024, this is above PDCO's average return on investment of 8.51%.
Patterson Companies Inc invested over the 12 months ending in its second quarter of 2024 $1,727 million

ROI fell compared to the first quarter of 2024, despite the net income growth of 28.03% from the first quarter of 2024.

Within the Healthcare sector 75 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Oct 28 2023 quarter, so far to 645, from total ROI ranking in the first quarter of 2024 at 679.

Definition and Formula of Return on Investment


Return On Investment (Oct 28 2023)
II. Quarter
(Jul 29 2023)
I. Quarter
(Apr 29 2023)
IV. Quarter
(Jan 28 2023)
III. Quarter
(Oct 29 2022)
II. Quarter
Y / Y Investment Change -1.32 % 3.35 % 3.93 % 1.87 % -
Y / Y Net Income Change -25.71 % 28.32 % 18.05 % -4.82 % 11.91 %
Investment (TTM) in Millions 1,668 1,724 1,795 1,720 1,690
Return On Investment (TTM) 11.56 % 12.32 % 12.02 % 11.47 % 11.68 %
PDCO's Overall Ranking # 645 # 679 # 712 # 823 # 671
Seq. Investment Change -3.3 % -3.92 % 4.32 % 1.81 % 1.28 %
Seq. Net Income Change 28.03 % -58.41 % 38.99 % 0.37 % 121.14 %
Net Income (TTM) in Millions 200 213 207 195 198




Return On Investment PDCO's Ranking
Within: No.
Industry # 18
Sector # 76
Overall # 645

Return On Investment Statistics
High Average Low
44.53 %
8.51 %
-43.05 %
(June 30. 2015)   (Jan 23 2021)







Financial Statements
Patterson Companies Inc's II. Quarter Investments $ 1,668 Millions PDCO's Balance sheet
Patterson Companies Inc's II. Quarter Income $ 40 Millions Quarterly PDCO's Income Statement
PDCO's Income by Division See PDCO's Income by Division


PDCO Annual Return On Investment (Apr 29 2023)
2023
(Apr 30 2022)
2022
(Apr 24 2021)
2021
(Apr 25 2020)
2020
(Apr 27 2019)
2019
Total Investments in Millions 1,795 1,727 1,663 1,643 2,397
Y / Y Investment Growth 3.93 % 3.82 % 1.25 % -31.46 % -6.49 %
Net Income in Millions 207 202 155 -589 83
Y / Y Net Income Growth 2.42 % 30.05 % - - -58.76 %
Annual Return On Investment 11.51 % 11.68 % 9.33 % -35.88 % 3.46 %


Annual Roi Comment
In the fiscal year 2023 ROI deteriorated to 11.51 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PDCO's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for PDCO's Competitors
Roi for Patterson Companies Inc's Suppliers
Return On Investment for PDCO's Customers

Other Ratios
PDCO's Roa PDCO's Inventory Turnover Ratio PDCO's Growth Rates PDCO's Dividend Statistics
PDCO's Profitability Ratios PDCO's Asset Turnover Ratio PDCO's Dividend Growth
PDCO's Roe PDCO's Valuation Ratios PDCO's Financial Strength Ratios PDCO's Dividend Payout Ratio



Companies with similar Return On Investment at Oct 28 2023, within Healthcare Sector ROI
Singular Genomics Systems Inc   31.10 %
Semler Scientific inc   30.96 %
National Research Corporation  30.72 %
Synaptogenix Inc   30.24 %
Denali Therapeutics Inc   29.23 %
Shockwave Medical Inc   28.94 %
Vaso Corporation  28.94 %
Arcturus Therapeutics Holdings Inc   28.09 %
Innoviva Inc   26.53 %
Johnson and Johnson  25.73 %
Protalix Biotherapeutics inc   25.29 %
Exagen Inc   24.03 %
Harmony Biosciences Holdings inc   23.58 %
Voyager Therapeutics Inc   23.09 %
Iradimed Corporation  21.83 %
Vertex Pharmaceuticals Inc  20.88 %
Point Biopharma Global Inc   20.60 %
Bellicum Pharmaceuticals Inc   19.61 %
Chemed Corporation  18.89 %
Rapid Micro Biosystems Inc   18.67 %
Zoetis Inc   18.66 %
Corcept Therapeutics Inc  18.61 %
Macrogenics Inc   18.47 %
Edwards Lifesciences Corporation  18.40 %
West Pharmaceutical Services Inc   17.67 %
Catalyst Pharmaceuticals Inc   17.53 %
Hca Healthcare Inc   16.59 %
Earth Science Tech Inc   16.40 %
International Stem Cell Corporation  15.54 %
Regeneron Pharmaceuticals Inc   15.08 %


Date modified: 2023-11-30T15:11:01+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com